OP Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
OP Asset Management's BMY Position: Q2 2026 in Review
OP Asset Management increased its Bristol-Myers Squibb (BMY) stake by 7.4% in Q2 2026, buying an estimated $908K and bringing the position to 228,545 shares worth $13.2M. The position accounts for 0.14% of the portfolio, ranked #120.
OP Asset Management first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $18.6M in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- OP Asset Management held 228,545 shares of Bristol-Myers Squibb worth $13.2M as of Q2 2026.
- OP Asset Management bought 15,818 Bristol-Myers Squibb shares in Q2 2026, an estimated $908K.
- Bristol-Myers Squibb made up 0.14% of OP Asset Management's portfolio in Q2 2026, its #120 holding.
- OP Asset Management first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
- OP Asset Management's Bristol-Myers Squibb position peaked at $18.6M in Q1 2025.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.